readthroughSign in
Oct 21, 2026Financing

Alpha Teknova launches common stock offering, discloses preliminary Q3 2026 results

The Hollister, California reagents maker filed a preliminary prospectus supplement dated October 20, 2026 for an undetermined number of shares, alongside early third-quarter revenue and margin estimates.

Alpha Teknova, Inc. filed a preliminary prospectus supplement dated October 20, 2026 to sell shares of common stock, with the number of shares not yet specified in the filing. The company's common stock is listed on the Nasdaq Global Market under the symbol "TKNO," and on October 19, 2026 its last reported sale price was $6.80 per share.1 The underwriters have been granted a 30-day option to purchase additional shares at the public offering price, less discounts and commissions.1

TD Securities (USA) LLC and William Blair & Company, L.L.C. are serving as representatives of the underwriters.1

Alongside the offering, Teknova disclosed preliminary unaudited results for the third quarter. The figures cover the three months ended September 30, 2026.1 Revenue for the quarter is estimated to be within $12.5 million and $12.7 million.1 Gross margin is estimated to be within 36.0% and 38.0%.1 Adjusted EBITDA is estimated to be within negative $1.2 million and negative $1.0 million.1 Cash and short-term investments as of September 30, 2026 are estimated to be $16.6 million.1

Total revenue is estimated to be up 19% to 21% versus the same period a year earlier.1 Gross margin is estimated to have expanded by 500 to 700 basis points year over year, driven primarily by top-line growth.1 The company said these are preliminary estimates subject to completion of its financial closing procedures, and the final figures could differ.1

The company intends to use net proceeds from the offering for general corporate purposes, including potentially repaying a portion of outstanding debt.1 Teknova's Second Amended and Restated Credit Agreement, dated March 3, 2025, is with MidCap Financial Trust as agent and lender.1

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.